Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (4425)	1/9/1998 2:52:00 PM
From: Gene Voss	Respond to of 23519

BigKNY3: I only stated it would be nice if financial incentives had no influence on data.Publishing financial involvements in advance of data reporting would help with investigator objectivity since everyone would be aware of possible conflicts of interest in advance. I,m well aware of P-N 's Vivus affiliation.My question is how do you reconcile his dramatic change of opinion regarding Muse after Pfizer started paying for studies.I may be wrong but current affiliations seem to carry more weight than past ones.Financial incentives have the potential of influencing even the most objective investigators . GV